ALPN   $64.97  0.03% Market Closed

Alpine Immune Sciences Inc
Total Cash 305.66M
totalCashPerShare 4.456
EBITDA -50.77M
Total Debt 9.65M
quickRatio 9.498
currentRatio 9.562
Total Revenue 56.52M
debtToEquity 2.902
Revenue/Share 1.044
ROA -0.10097
ROE -0.14669
grossProfits
freeCashflow -41.41M
operatingCashflow -80.55M
earningsGrowth
revenueGrowth -0.251
grossMargins -0.48228002
ebitdaMargins -0.89827
operatingMargins -3.22753
profitMargins -0.65172
enterpriseValue 4.16B
forwardPE -32.485
floatShares 47.88M
sharesOutstanding 68.60M
sharesShort 3.89M
sharesShortPriorMonth 5.28M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.99%
Short Ratio help_outline 0.96%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 5.075
Price To Book help_outline 12.80
earningsQuarterlyGrowth
netIncomeToCommon -36.84M
trailingEps -0.64%
forwardEps -2.00%
enterpriseToEbitda -81.95
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.42 2Q 2024
institutionsCount 243
lastUpdated July 19, 2024, 4:46 a.m.